Till Tobias Böhlen (Till T Böhlen)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Brain Metastases

Radiation Induced

Top Venues

Medical physics

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Remy Kinj, Andreas Felix Hottinger, Till Tobias Böhlen, Mahmut Ozsahin, Véronique Vallet, Vincent Dunet, Hasna Bouchaab, Solange Peters, Constantin Tuleasca, Jean Bourhis, Luis Schiappacasse
Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis. Cancers 16 (9) (2024)
Remy Kinj, Andreas Felix Hottinger, Till Tobias Böhlen, Mahmut Ozsahin, Véronique Vallet, Vincent Dunet, Hasna Bouchaab, Solange Peters, Constantin Tuleasca, Jean Bourhis, Luis Schiappacasse
Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis. Cancers 16 (9) (2024)
Till Tobias Böhlen, Jean-François Germond, Erik Traneus, Veronique Vallet, Laurent Desorgher, Esat Mahmut Ozsahin, François Bochud, Jean Bourhis, Raphaël Moeckli
3D-conformal very-high energy electron therapy as candidate modality for FLASH-RT: A treatment planning study for glioblastoma and lung cancer. Medical physics (2023)
Till Tobias Böhlen, Jean-François Germond, Jean Bourhis, Claude Bailat, François Bochud, Raphaël Moeckli
The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues. Medical physics (2022)
Carla Rohrer Bley, Friederike Wolf, Patrik Gonçalves Jorge, Veljko Grilj, Ioannis Petridis, Benoit Petit, Till Tobias Böhlen, Raphaël Moeckli, Charles Limoli, Jean Bourhis, Valeria S Meier, Marie-Catherine Vozenin
Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)